New This Week
May 29, 2017
- Diabetic Foot Ulcers: Wound Management
- New and Updated American College of Radiology Guidelines on:
- Chronic Chest Pain—High Probability of Coronary Artery Disease
- Chronic Hip Pain
- Chronic Liver Disease
- Chylothorax Treatment Planning
- Dyspnea—Suspected Cardiac Origin
- Evaluation of Nipple Discharge
May 29, 2017
G-I-N NA Webinar Series: USPSTF Methods for Making Recommendations for Diverse Populations: When: May 30, 2017 12:30PM ET (11:30PM CT; 10:30AM MT; 9:30AM PT); Register: https://goo.gl/OM47xy ; The U.S. Preventive Services Task Force (USPSTF) makes evidence-based recommendations on clinical preventive services for primary care clinicians and their patients. The Evidence-based Practice Centers (EPCs) support the USPSTF with systematic reviews that are used as the basis for the recommendations. Hear what one EPC and the USPSTF have done to improve recommendations for diverse populations.
U.S. FDA Advisory
May 16, 2017: Canagliflozin (Invokana, Invokamet) : Based on new data from two large clinical trials, the FDA has concluded that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. FDA is requiring new warnings, including the most prominent Boxed Warning, to be added to the canagliflozin drug labels to describe this risk.
NGC supports AHRQ's mission to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable by providing objective, detailed information on clinical practice guidelines, and to further their dissemination, implementation, and use in order to inform health care decisions.